Shailja C Shah1, Hamed Khalili2, Corinne Gower-Rousseau3, Ola Olen4, Eric I Benchimol5, Elsebeth Lynge6, Kári R Nielsen7, Paul Brassard8, Maria Vutcovici9, Alain Bitton9, Charles N Bernstein10, Desmond Leddin11, Hala Tamim11, Tryggvi Stefansson12, Edward V Loftus13, Bjørn Moum14, Whitney Tang15, Siew C Ng15, Richard Gearry16, Brankica Sincic17, Sally Bell18, Bruce E Sands19, Peter L Lakatos20, Zsuzsanna Végh20, Claudia Ott21, Gilaad G Kaplan22, Johan Burisch23, Jean-Frederic Colombel19. 1. Division of Gastroenterology, Mount Sinai Hospital, New York, New York; Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: shailja.c.shah@vanderbilt.edu. 2. Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. 3. Public Health Unit, Epimad Registre, Lille University Hospital, France; INSERM LIRIC, UMR 995, Lille University, France. 4. Department of Medicine, Karolinska Institutet, Stockholm, Sweden. 5. CHEO Inflammatory Bowel Disease Centre, Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada; Department of Pediatrics and School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada. 6. Division of Gastroenterology, University of Copenhagen, Copenhagen, Denmark. 7. Division of Gastroenterology, National Hospital, Tórshavn, Faroe Islands. 8. Department of Medicine, McGill University, Montreal, Quebec, Canada. 9. Department of Gastroenterology, McGill University Health Center, Montreal, Quebec, Canada. 10. Division of Gastroenterology, University of Manitoba, Winnipeg, Manitoba, Canada. 11. Division of Gastroenterology, Dalhousie University, Halifax, Nova Scotia, Canada. 12. Division of Gastroenterology, National University Hospital of Iceland, Reykjavík, Iceland. 13. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, New York. 14. Department of Gastroenterology, Oslo University Hospital and University of Oslo, Oslo, Norway. 15. Department of Medicine and Therapeutics, Institute of Digestive Disease, LKS Institute of Health Science, State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong. 16. Division of Gastroenterology, University of Otago, Christchurch, New Zealand. 17. Division of Gastroenterology, University of Rijeka, Rijeka, Croatia. 18. Division of Gastroenterology, St. Vincent's Hospital, Melbourne, Australia. 19. Division of Gastroenterology, Mount Sinai Hospital, New York, New York. 20. Division of Gastroenterology, Semmelweis University, Budapest, Hungary. 21. Division of Gastroenterology, University of Regensburg, Regensburg, Germany. 22. Department of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada. 23. Department of Gastroenterology, North Zealand University Hospital, Frederikssund, Denmark.
Abstract
BACKGROUND & AIMS: Although the incidence of inflammatory bowel diseases (IBDs) varies with age, few studies have examined variations between the sexes. We therefore used population data from established cohorts to analyze sex differences in IBD incidence according to age at diagnosis. METHODS: We identified population-based cohorts of patients with IBD for which incidence and age data were available (17 distinct cohorts from 16 regions of Europe, North America, Australia, and New Zealand). We collected data through December 2016 on 95,605 incident cases of Crohn's disease (CD) (42,831 male and 52,774 female) and 112,004 incident cases of ulcerative colitis (UC) (61,672 male and 50,332 female). We pooled incidence rate ratios of CD and UC for the combined cohort and compared differences according to sex using random effects meta-analysis. RESULTS: Female patients had a lower risk of CD during childhood, until the age range of 10-14 years (incidence rate ratio, 0.70; 95% CI, 0.53-0.93), but they had a higher risk of CD thereafter, which was statistically significant for the age groups of 25-29 years and older than 35 years. The incidence of UC did not differ significantly for female vs male patients (except for the age group of 5-9 years) until age 45 years; thereafter, men had a significantly higher incidence of ulcerative colitis than women. CONCLUSIONS: In a pooled analysis of population-based studies, we found age at IBD onset to vary with sex. Further studies are needed to investigate mechanisms of sex differences in IBD incidence.
BACKGROUND & AIMS: Although the incidence of inflammatory bowel diseases (IBDs) varies with age, few studies have examined variations between the sexes. We therefore used population data from established cohorts to analyze sex differences in IBD incidence according to age at diagnosis. METHODS: We identified population-based cohorts of patients with IBD for which incidence and age data were available (17 distinct cohorts from 16 regions of Europe, North America, Australia, and New Zealand). We collected data through December 2016 on 95,605 incident cases of Crohn's disease (CD) (42,831 male and 52,774 female) and 112,004 incident cases of ulcerative colitis (UC) (61,672 male and 50,332 female). We pooled incidence rate ratios of CD and UC for the combined cohort and compared differences according to sex using random effects meta-analysis. RESULTS: Female patients had a lower risk of CD during childhood, until the age range of 10-14 years (incidence rate ratio, 0.70; 95% CI, 0.53-0.93), but they had a higher risk of CD thereafter, which was statistically significant for the age groups of 25-29 years and older than 35 years. The incidence of UC did not differ significantly for female vs male patients (except for the age group of 5-9 years) until age 45 years; thereafter, men had a significantly higher incidence of ulcerative colitis than women. CONCLUSIONS: In a pooled analysis of population-based studies, we found age at IBD onset to vary with sex. Further studies are needed to investigate mechanisms of sex differences in IBD incidence.
Authors: Wendy A Goodman; Sarah M Bedoyan; Hannah L Havran; Brian Richardson; Mark J Cameron; Theresa T Pizarro Journal: Proc Natl Acad Sci U S A Date: 2020-07-06 Impact factor: 11.205
Authors: Shilpa Grover; Michael Dougan; Kevin Tyan; Anita Giobbie-Hurder; Steven M Blum; Jeffrey Ishizuka; Taha Qazi; Rawad Elias; Kruti B Vora; Alex B Ruan; William Martin-Doyle; Michael Manos; Lauren Eastman; Meredith Davis; Maria Gargano; Rizwan Haq; Elizabeth I Buchbinder; Ryan J Sullivan; Patrick A Ott; F Stephen Hodi; Osama E Rahma Journal: Cancer Date: 2020-06-22 Impact factor: 6.860
Authors: Po-Hong Liu; Kristin E Burke; Ashwin N Ananthakrishnan; Paul Lochhead; Ola Olen; Jonas F Ludvigsson; James M Richter; Andrew T Chan; Hamed Khalili Journal: Clin Gastroenterol Hepatol Date: 2018-12-06 Impact factor: 11.382
Authors: Elizabeth A Erwin; Aishwarya Navalpakam; Ruchi Singla; Joshua Bolender; Lisa J Workman; Thomas A E Platts-Mills Journal: J Allergy Clin Immunol Pract Date: 2019-11-11
Authors: Kristine H Allin; Rikke K Jacobsen; Ryan C Ungaro; Jean-Frederic Colombel; Alexander Egeberg; Marie Villumsen; Tine Jess Journal: J Crohns Colitis Date: 2021-09-25 Impact factor: 9.071